News & Information
Men Over 40 With BRCA2 Mutations Must Get Prostate Cancer Screening, Experts Say Men Over 40 With BRCA2 Mutations Must Get Prostate Cancer Screening, Experts Say

Forbes, November 5, 2019,
Written by Victoria Forstar, healthcare contributor
Increasing Diversity in Clinical Trials

Clinical trials lead to the approval of new drugs.  A recent article reported that black enrollment is extremely low; limiting our understanding of how these drugs effect blacks...
One Two Punch could slow the spread of cancer

There is no one pathway, which controls prostate cancer growth, more clinical trials are being designed using more than one drug. This ONE TWO punch design could slow the spread of cancer. 
PHEN “Daddy’s Boys” Performance a Hit in Boston PHEN “Daddy’s Boys” Performance a Hit in Boston
Boston was the 14th city where the play has been performed and the audience numbered 500.
PHEN Hosts Workshop In Boston PHEN Hosts Workshop In Boston
PHEN hosted an educational workshop. Dr. J. Jacques Carter, Beth Israel Deaconess Hospital and Dr. Jairam Eswara from St. Elizabeth’s Medical Center were the presenters
ASCO Releases Guideline on Addressing Osteoporosis Risk With Nonmetastatic Cance

Cancer and therapies used to treat it may raise a patient’s risk of osteoporosis.
Partners